Policymakers across party lines have increasingly focused on the role pharmacy benefit managers (PBMs) play in driving prescription drug costs. The Consolidated Appropriations Act of 2026 takes steps to address longstanding concerns raised by consumers and pharmacies, particularly with respect to pricing in Medicare Part D. In the second installment of his interview with The American Journal of Managed Care, Jesse Dresser discusses how CMS may approach these changes and what further legislative action may be needed to address PBM practices more broadly.
Listen to the full interview with the American Journal of Managed Care.
Also published in Time.News.
